-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Palvella Therapeutics with Buy Rating, Announces Price Target of $167

Benzinga·12/05/2025 12:46:06
语音播报
BTIG analyst Jeet Mukherjee initiates coverage on Palvella Therapeutics (NASDAQ:PVLA) with a Buy rating and announces Price Target of $167.